Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Assets (2021 - 2025)

Caribou Biosciences (CRBU) has disclosed Return on Assets for 5 consecutive years, with 0.5% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Assets fell 14.0% to 0.5% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.5%, a 14.0% decrease, with the full-year FY2024 number at 0.4%, down 15.0% from a year prior.
  • Return on Assets was 0.5% for Q2 2025 at Caribou Biosciences, down from 0.41% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.15% in Q4 2021 to a low of 0.5% in Q2 2025.
  • A 5-year average of 0.29% and a median of 0.27% in 2022 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 1bps in 2023; the steepest drop was -16bps in 2023.
  • Caribou Biosciences' Return on Assets stood at 0.15% in 2021, then crashed by -86bps to 0.28% in 2022, then increased by 5bps to 0.26% in 2023, then tumbled by -39bps to 0.36% in 2024, then plummeted by -39bps to 0.5% in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Return on Assets are 0.5% (Q2 2025), 0.41% (Q1 2025), and 0.36% (Q2 2024).